These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20852190)

  • 1. Unraveling the binding mechanism of trivalent tumor necrosis factor ligands and their receptors.
    Reis CR; van Assen AH; Quax WJ; Cool RH
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002808. PubMed ID: 20852190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor oligomerization and beyond: a case study in bone morphogenetic proteins.
    Heinecke K; Seher A; Schmitz W; Mueller TD; Sebald W; Nickel J
    BMC Biol; 2009 Sep; 7():59. PubMed ID: 19735544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.
    Vitovski S; Phillips JS; Sayers J; Croucher PI
    J Biol Chem; 2007 Oct; 282(43):31601-9. PubMed ID: 17702740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimerization of an apoptogenic TRAIL-mimicking peptide by using adamantane-based dendrons.
    Lamanna G; Smulski CR; Chekkat N; Estieu-Gionnet K; Guichard G; Fournel S; Bianco A
    Chemistry; 2013 Jan; 19(5):1762-8. PubMed ID: 23239456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis.
    Harper N; Hughes M; MacFarlane M; Cohen GM
    J Biol Chem; 2003 Jul; 278(28):25534-41. PubMed ID: 12721308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5.
    Gasparian ME; Chernyak BV; Dolgikh DA; Yagolovich AV; Popova EN; Sycheva AM; Moshkovskii SA; Kirpichnikov MP
    Apoptosis; 2009 Jun; 14(6):778-87. PubMed ID: 19412666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A minimal mathematical model for the initial molecular interactions of death receptor signalling.
    Winkel C; Neumann S; Surulescu C; Scheurich P
    Math Biosci Eng; 2012 Jul; 9(3):663-83. PubMed ID: 22881031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering death receptor ligands for cancer therapy.
    Wajant H; Gerspach J; Pfizenmaier K
    Cancer Lett; 2013 May; 332(2):163-74. PubMed ID: 21236560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand.
    Chou AH; Tsai HF; Lin LL; Hsieh SL; Hsu PI; Hsu PN
    J Immunol; 2001 Aug; 167(3):1347-52. PubMed ID: 11466352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of receptor-induced signaling complex formation by the kinetics of ligand/receptor interaction.
    Krippner-Heidenreich A; Tübing F; Bryde S; Willi S; Zimmermann G; Scheurich P
    J Biol Chem; 2002 Nov; 277(46):44155-63. PubMed ID: 12215450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study.
    Wassenaar TA; Quax WJ; Mark AE
    Proteins; 2008 Feb; 70(2):333-43. PubMed ID: 17671978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surviving apoptosis: life-death signaling in single cells.
    Flusberg DA; Sorger PK
    Trends Cell Biol; 2015 Aug; 25(8):446-58. PubMed ID: 25920803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stoichiometry of LTbetaR binding to LIGHT.
    Eldredge J; Berkowitz S; Corin AF; Day ES; Hayes D; Meier W; Strauch K; Zafari M; Tadi M; Farrington GK
    Biochemistry; 2006 Aug; 45(33):10117-28. PubMed ID: 16906770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activity of Erk1/2 and NF-κB protects human endometrial stromal cells from death receptor-mediated apoptosis.
    Fluhr H; Spratte J; Bredow M; Heidrich S; Zygmunt M
    Reprod Biol; 2013 Jun; 13(2):113-21. PubMed ID: 23719115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted cancer immunotherapy using ligands of the tumor necrosis factor super-family.
    Bremer E; de Bruyn M; Wajant H; Helfrich W
    Curr Drug Targets; 2009 Feb; 10(2):94-103. PubMed ID: 19199904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Test of Receptor Binding Kinetics for Ligands in Tumor Necrosis Factor Superfamily by Computational Simulations.
    Su Z; Wu Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAIL-induced signalling and apoptosis.
    MacFarlane M
    Toxicol Lett; 2003 Apr; 139(2-3):89-97. PubMed ID: 12628743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
    J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.